Ibrahim Alabdulaali
Papers
5
Total Citations
184
H-Index
5
About
Dr. Ibrahim Alabdulaali is a leading urologic surgeon and researcher whose work centers on advancing robot-assisted surgery for complex kidney and prostate cancers. His major contributions lie in demonstrating the feasibility and safety of robot-assisted partial nephrectomy (RAPN) for challenging renal masses, including high-complexity tumors with PADUA scores of 10 or greater. His landmark 2016 study comparing Trifecta and Pentafecta outcomes between T1a and T1b renal masses (71 citations) provided critical evidence that RAPN is a viable option even for larger tumors. Dr. Alabdulaali also showed that the Da Vinci Xi and Si platforms yield equivalent perioperative outcomes during RAPN (41 citations), offering practical guidance for surgical teams. His work extends to prostate cancer, where he reported 5-year oncological outcomes from one of the largest Asian series of robot-assisted radical prostatectomies (800 patients, 64-month follow-up). Notably, he pioneered a combined Retzius-sparing robot-assisted radical prostatectomy and partial nephrectomy for synchronous cancers (14 citations), showcasing innovative approaches to multi-organ disease. With cumulative citations exceeding 180, Dr. Alabdulaali’s research has shaped best practices in minimally invasive urologic oncology, particularly for Asian patient populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5